119 related articles for article (PubMed ID: 26891147)
1. Modeling Chemotherapy Resistant Leukemia In Vitro.
Slone WL; Moses BS; Evans R; Piktel D; Martin KH; Petros W; Craig M; Gibson LF
J Vis Exp; 2016 Feb; (108):e53645. PubMed ID: 26891147
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow microenvironment modulation of acute lymphoblastic leukemia phenotype.
Moses BS; Slone WL; Thomas P; Evans R; Piktel D; Angel PM; Walsh CM; Cantrell PS; Rellick SL; Martin KH; Simpkins JW; Gibson LF
Exp Hematol; 2016 Jan; 44(1):50-9.e1-2. PubMed ID: 26407636
[TBL] [Abstract][Full Text] [Related]
3. Co-culture model of B-cell acute lymphoblastic leukemia recapitulates a transcription signature of chemotherapy-refractory minimal residual disease.
Rellick SL; Hu G; Piktel D; Martin KH; Geldenhuys WJ; Nair RR; Gibson LF
Sci Rep; 2021 Aug; 11(1):15840. PubMed ID: 34349149
[TBL] [Abstract][Full Text] [Related]
4. Targeting the leukemia microenvironment.
Konopleva M; Andreeff M
Curr Drug Targets; 2007 Jun; 8(6):685-701. PubMed ID: 17584025
[TBL] [Abstract][Full Text] [Related]
5. Mimicking the Acute Myeloid Leukemia Niche for Molecular Study and Drug Screening.
Houshmand M; Soleimani M; Atashi A; Saglio G; Abdollahi M; Nikougoftar Zarif M
Tissue Eng Part C Methods; 2017 Feb; 23(2):72-85. PubMed ID: 28007011
[TBL] [Abstract][Full Text] [Related]
6. BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy.
Slone WL; Moses BS; Hare I; Evans R; Piktel D; Gibson LF
Oncotarget; 2016 Apr; 7(17):23439-53. PubMed ID: 27015556
[TBL] [Abstract][Full Text] [Related]
7. A novel three-dimensional stromal-based model for in vitro chemotherapy sensitivity testing of leukemia cells.
Aljitawi OS; Li D; Xiao Y; Zhang D; Ramachandran K; Stehno-Bittel L; Van Veldhuizen P; Lin TL; Kambhampati S; Garimella R
Leuk Lymphoma; 2014 Feb; 55(2):378-91. PubMed ID: 23566162
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle arrest of Jurkat cells by leukemic bone marrow stromal cells: possible mechanisms and involvement of CRIF1.
Zhang X; Ran Q; Li Z; Liu Y; Liang X; Chen X
Transplant Proc; 2011 Sep; 43(7):2770-3. PubMed ID: 21911160
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Targeting of the Leukaemia Microenvironment.
Kuek V; Hughes AM; Kotecha RS; Cheung LC
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206957
[TBL] [Abstract][Full Text] [Related]
10. Leukemia Stem Cells Microenvironment.
Tabe Y; Konopleva M
Adv Exp Med Biol; 2017; 1041():19-32. PubMed ID: 29204827
[TBL] [Abstract][Full Text] [Related]
11. Role of bone marrow adipocytes in leukemia and chemotherapy challenges.
Samimi A; Ghanavat M; Shahrabi S; Azizidoost S; Saki N
Cell Mol Life Sci; 2019 Jul; 76(13):2489-2497. PubMed ID: 30715556
[TBL] [Abstract][Full Text] [Related]
12. Three-Dimensional Microfluidic Tri-Culture Model of the Bone Marrow Microenvironment for Study of Acute Lymphoblastic Leukemia.
Bruce A; Evans R; Mezan R; Shi L; Moses BS; Martin KH; Gibson LF; Yang Y
PLoS One; 2015; 10(10):e0140506. PubMed ID: 26488876
[TBL] [Abstract][Full Text] [Related]
13. Effect of Cx43 gene-modified leukemic bone marrow stromal cells on the regulation of Jurkat cell line in vitro.
Zhang X; Liu Y; Si YJ; Chen XH; Li ZJ; Gao L; Gao L; Zhang C
Leuk Res; 2012 Feb; 36(2):198-204. PubMed ID: 22030334
[TBL] [Abstract][Full Text] [Related]
14. Primary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrow.
Bam R; Khan S; Ling W; Randal SS; Li X; Barlogie B; Edmondson R; Yaccoby S
BMC Cancer; 2015 Nov; 15():864. PubMed ID: 26545722
[TBL] [Abstract][Full Text] [Related]
15. Concise Review: Adaptation of the Bone Marrow Stroma in Hematopoietic Malignancies: Current Concepts and Models.
Doron B; Handu M; Kurre P
Stem Cells; 2018 Mar; 36(3):304-312. PubMed ID: 29235199
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models.
Benito J; Ramirez MS; Millward NZ; Velez J; Harutyunyan KG; Lu H; Shi YX; Matre P; Jacamo R; Ma H; Konoplev S; McQueen T; Volgin A; Protopopova M; Mu H; Lee J; Bhattacharya PK; Marszalek JR; Davis RE; Bankson JA; Cortes JE; Hart CP; Andreeff M; Konopleva M
Clin Cancer Res; 2016 Apr; 22(7):1687-98. PubMed ID: 26603259
[TBL] [Abstract][Full Text] [Related]
17. Stromal cells expressing elevated VCAM-1 enhance survival of B lineage tumor cells.
Hall BM; Fortney JE; Taylor L; Wood H; Wang L; Adams S; Davis S; Gibson LF
Cancer Lett; 2004 Apr; 207(2):229-39. PubMed ID: 15072833
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and Functional Alterations of Hematopoietic Stem and Progenitor Cells in an In Vitro Leukemia-Induced Microenvironment.
Vernot JP; Bonilla X; Rodriguez-Pardo V; Vanegas NP
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216566
[TBL] [Abstract][Full Text] [Related]
19. [Influence of chemotherapy on expression of TRAIL in primary acute leukemic cells].
Liu YF; Chen SM; Sun H; Dong JX; Zhang QT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):481-4. PubMed ID: 16800925
[TBL] [Abstract][Full Text] [Related]
20. The geldanamycin derivative 17-AAG decreases VEGF secretion and leukemia growth support by trisomy 8 myelodysplastic syndrome bone marrow stromal cells.
Hawkins LM; Narendran A
Pediatr Hematol Oncol; 2005 Mar; 22(2):115-25. PubMed ID: 15804996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
